TrialSignal
Clinical trial intelligence report
Brain Function and Psychological Assessment in Patients With Autoimmune Hemolytic Anemia Undergoing Cell Therapy
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jul 28, 2026
Report code
NCT06921980-Jul 28, 2026
NCT ID
NCT06921980
Status
RECRUITING
Phase
registry-stage
Sponsor
Institute of Hematology & Blood Diseases Hospital, China
Executive brief
Investment-Ready Snapshot
Brain Function and Psychological Assessment in Patients With Autoimmune Hemolytic Anemia Undergoing Cell Therapy is a registry-stage clinical asset sponsored by Institute of Hematology & Blood Diseases Hospital, China in CAR T-cell Therapy, Autoimmune Hemolytic Anemia, Brain Function, Psychological Well-Being. SEO and diligence focus: Brain function and psychological assessment, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT06921980
Indication
CAR T-cell Therapy
Modality
cell therapy
Target
Brain function and psychological assessment
Intervention
Brain function and psychological assessment
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.